Basic Fibroblast Growth Factor Inhibits Osteoclast Formation Induced by 1α,25-Dihydroxyvitamin D3 through Suppressing the Production of Osteoclast Differentiation Factor
N. Nakagawa(SHOWA Medical University), Kanji Higashio(Megmilk Snow Brand (Japan)), Naoki Kobayashi(Megmilk Snow Brand (Japan)), Hisataka Yasuda(SHOWA Medical University), Kyoji Yamaguchi(Daiichi-Sankyo (Japan)), Tomonori Morinaga(SHOWA Medical University), Kazuki Yano(Megmilk Snow Brand (Japan)), Nobuyuki Shima(SHOWA Medical University), Hitoshi Fujimoto(National Institute of Health Sciences), Shin-ichi Mochizuki(Megmilk Snow Brand (Japan))
Cited by 13
Related Papers
Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
|Proceedings of the National Academy of Sciences|1998|4.3k
Tumor Necrosis Factor α Stimulates Osteoclast Differentiation by a Mechanism Independent of the Odf/Rankl–Rank Interaction
|The Journal of Experimental Medicine|2000|1.3k
Identity of Osteoclastogenesis Inhibitory Factor (OCIF) and Osteoprotegerin (OPG): A Mechanism by which OPG/OCIF Inhibits Osteoclastogenesis<i>in Vitro</i><sup>1</sup>
|Endocrinology|1998|1.2k
RANK Is the Essential Signaling Receptor for Osteoclast Differentiation Factor in Osteoclastogenesis
|Biochemical and Biophysical Research Communications|1998|746